Related Experiment Videos
Susceptibility of Encephalitozoon cuniculi to several drugs in vitro
F F Franssen1, J T Lumeij, F van Knapen
1Department of Parasitology and Tropical Veterinary Medicine, University of Utrecht, The Netherlands.
Abstract:
In the light of the increased incidence of human Encephalitozoon infections and the absence of an established treatment protocol, a simple in vitro testing method to compare activities of drugs against Encephalitozoon cuniculi was developed. With this in vitro method, the 50% inhibitory concentrations of fumagillin, thiabendazole, albendazole, oxibendazole, and propamidine isethionate for E. cuniculi in rabbit kidney cells were determined. Itraconazole, toltrazuril, metronidazole, ronidazole, and ganciclovir were ineffective in this testing system.
Insights
A new in vitro testing method was developed to evaluate drugs against Encephalitozoon infections. This method identified effective treatments like fumagillin and albendazole for Encephalitozoon cuniculi.
Area of Science:
- Parasitology
- Infectious Diseases
- Drug Discovery
Background:
- Human Encephalitozoon infections are increasing.
- No standard treatment protocols exist for Encephalitozoon infections.
Purpose of the Study:
- To develop a simple in vitro method for comparing drug efficacy against Encephalitozoon cuniculi.
- To determine the 50% inhibitory concentrations (IC50) of various drugs against E. cuniculi.
Main Methods:
- Developed a novel in vitro assay using rabbit kidney cells.
- Tested the activity of fumagillin, thiabendazole, albendazole, oxibendazole, propamidine isethionate, itraconazole, toltrazuril, metronidazole, ronidazole, and ganciclovir.
Main Results:
- Fumagillin, thiabendazole, albendazole, oxibendazole, and propamidine isethionate demonstrated activity against E. cuniculi in vitro.
- Itraconazole, toltrazuril, metronidazole, ronidazole, and ganciclovir were ineffective in this testing system.
Conclusions:
- The developed in vitro method is effective for screening anti-Encephalitozoon drugs.
- Several existing drugs show promise for treating Encephalitozoon infections, warranting further investigation.